Réjean Ruel
- Pharmacology top 5%
- Inflammatory mediators and NSAID effects 4
- Molecular Biology top 5%
- Steroid Chemistry and Biochemistry 5
- Chemical Synthesis and Analysis 3
- Biochemistry top 5%
- Organic Chemistry top 5%
- Synthetic Organic Chemistry Methods 6
- Asymmetric Synthesis and Catalysis 4
- Coordination Chemistry and Organometallics 3
- Immunology top 10%
-
- Acute Myeloid Leukemia Research 3
-
- Cancer Treatment and Pharmacology 3
- Co-authors
- Nancy A. ThornberryErin P. PetersonDonald W. NicholsonMargarita García‐CalvoBarbara LeitingYves GareauMarc LabelleMichel Gallant
- Partner nations
- CanadaUnited StatesGermany
In The Last Decade
Réjean Ruel
30 papers receiving 2.3k citations
Hit Papers
Peers
Comparison fields: 5 of 116
- Pharmacology 345
- Molecular Biology 1.4k
- Biochemistry 133
- Organic Chemistry 469
- Immunology 315
Countries citing papers authored by Réjean Ruel
This map shows the geographic impact of Réjean Ruel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Réjean Ruel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Réjean Ruel more than expected).
Fields of papers citing papers by Réjean Ruel
This network shows the impact of papers produced by Réjean Ruel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Réjean Ruel. The network helps show where Réjean Ruel may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Réjean Ruel, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 18 | |
| 3 | 2024 | 1 | |
| 4 | 2017 | 28 | |
| 5 | 2014 | 84 | |
| 6 | 2003 | 17 | |
| 7 | 2002 | 37 | |
| 8 | 2000 | 473 | |
| 9 | 1999 | 18 | |
| 10 | 1999 | 77 | |
| 11 | Inhibition of Human Caspases by Peptide-based and Macromolecular Inhibitorsbreakdown → | 1998 | 859 |
| 12 | 1996 | 14 | |
| 13 | 1996 | 356 | |
| 14 | 1993 | 37 | |
| 15 | 1992 | 47 | |
| 16 | 1991 | 2 | |
| 17 | 1990 | 7 | |
| 18 | 1990 | 28 | |
| 19 | 1989 | 0 | |
| 20 | 1986 | 40 |
About Réjean Ruel
Réjean Ruel is a scholar working on Organic Chemistry, Pharmaceutical Science and Oncology, having authored 32 papers that have together received 2.4k indexed citations. Recurring topics across this work include Synthetic Organic Chemistry Methods (6 papers), Steroid Chemistry and Biochemistry (5 papers), Asymmetric Synthesis and Catalysis (4 papers), Inflammatory mediators and NSAID effects (4 papers), Acute Myeloid Leukemia Research (3 papers), Chemical Synthesis and Analysis (3 papers), Coordination Chemistry and Organometallics (3 papers) and Cancer Treatment and Pharmacology (3 papers). The work is most often cited by research in Pharmacology (345 citations), Molecular Biology (1.4k citations) and Biochemistry (133 citations). Réjean Ruel has collaborated with scholars based in Canada, United States and Germany. Frequent co-authors include Nancy A. Thornberry, Erin P. Peterson, Donald W. Nicholson, Margarita García‐Calvo, Barbara Leiting, Yves Gareau, Marc Labelle, Michel Gallant, Pierre Deslongchamps and Dita Rasper. Their work appears in journals such as Journal of Biological Chemistry, Blood and Nature Methods.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.